Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Omega 3 PUFA for the Vascular Component of Age-related Cognitive Decline

Authors not listed

Oregon Health and Science University · 2014

Abstract

Brain scans can help identify changes that appear to increase risk for cognitive decline and dementia. Some of these brain changes are thought to reflect actual damage to the small blood vessels that support normal brain function. This clinical trial will determine whether an omega 3 polyunsaturated fatty acid (PUFA) therapy can promote brain health by supporting the small blood vessels in the brain over 3 years in older adults at high risk for cognitive decline and dementia of Alzheimer's type.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-23 MST

Cite this

APA
Anonymous. (2014). Omega 3 PUFA for the Vascular Component of Age-related Cognitive Decline. <em>Oregon Health and Science University</em>. https://clinicaltrials.gov/study/NCT01953705
Vancouver
Anonymous. Omega 3 PUFA for the Vascular Component of Age-related Cognitive Decline. Oregon Health and Science University. 2014.
BibTeX
@misc{anon2014OmegaP, title = {Omega 3 PUFA for the Vascular Component of Age-related Cognitive Decline}, author = {Anonymous}, journal = {Oregon Health and Science University}, year = {2014}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings